Immune surveillance as a pharmacological target in the early stages of cancer

  • Front Mol Biosci. 2025 Jul 25:12:1643024. doi: 10.3389/fmolb.2025.1643024.
Hongfei Jiang  1  2 ,  Zhun Wei  1  2 ,  Haibo Zhao  1  2
Affiliations
  • 1. The Affiliated Hospital of Qingdao University and Qingdao Cancer Institute, Qingdao, China.
  • 2. Department of Pharmacology, School of Pharmacy, Qingdao University Medical College, Qingdao University, Qingdao, China.
PMID: 40786058 DOI: 10.3389/fmolb.2025.1643024
Keywords
early cancer interception; immune surveillance; immunoprevention; pharmacological modulation; tumor microenvironment (TME).